Hexem Bio

Healthcare systems face ongoing challenges in blood supply and regenerative treatment options. HexemBio is developing organoid-based systems designed to support the production of blood and enable new therapeutic approaches across regenerative medicine. The company is supported by a multidisciplinary team spanning medicine, biology, and engineering.